ENHANCED VASCULAR-PERMEABILITY IN SOLID TUMOR IS MEDIATED BY NITRIC-OXIDE AND INHIBITED BY BOTH NEW NITRIC-OXIDE SCAVENGER AND NITRIC-OXIDE SYNTHASE INHIBITOR

被引:177
作者
MAEDA, H
NOGUCHI, Y
SATO, K
AKAIKE, T
机构
[1] Department of Microbiology, Kumamoto University School of Medicine, Kumamoto, 860
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1994年 / 85卷 / 04期
关键词
TUMOR VASCULAR PERMEABILITY; NITRIC OXIDE; NITRIC OXIDE SCAVENGER; BRADYKININ;
D O I
10.1111/j.1349-7006.1994.tb02362.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A newly discovered nitric oxide radical scavenger, an imidazolineoxyl N-oxide derivative, was used to investigate the role of nitric oxide radical (.NO) in the vascular permeability enhancement of solid tumor. Sarcoma-180 solid tumor in ddY mice was used for this experiment. Electron spin resonance spectroscopy was used to quantitate the reacted and unreacted scavenger. The results showed that extensive extravasation, assessed by intravenous injection of Evans blue, could be greatly suppressed by both .NO scavenger administered orally and .NO synthase inhibitor administrated intraperitoneally. This indicates that .NO is responsible for the vascular permeability in solid tumors.
引用
收藏
页码:331 / 334
页数:4
相关论文
共 24 条
  • [1] ANTAGONISTIC ACTION OF IMIDAZOLINEOXYL N-OXIDES AGAINST ENDOTHELIUM-DERIVED RELAXING FACTOR .NO THROUGH A RADICAL REACTION
    AKAIKE, T
    YOSHIDA, M
    MIYAMOTO, Y
    SATO, K
    KOHNO, M
    SASAMOTO, K
    MIYAZAKI, K
    UEDA, S
    MAEDA, H
    [J]. BIOCHEMISTRY, 1993, 32 (03) : 827 - 832
  • [2] AKAIKE T, 1994, IN PRESS 3RD P INT M
  • [3] INCREASED VASCULAR-PERMEABILITY IN ORGANS MEDIATED BY THE SYSTEMIC ADMINISTRATION OF LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2 IN MICE
    ETTINGHAUSEN, SE
    PURI, RK
    ROSENBERG, SA
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1988, 80 (03): : 177 - 188
  • [4] WHAT IS THE EVIDENCE THAT TUMORS ARE ANGIOGENESIS DEPENDENT
    FOLKMAN, J
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1990, 82 (01): : 4 - 6
  • [5] HORI K, 1985, J NATL CANCER I, V74, P453
  • [6] IWAI K, 1984, CANCER RES, V44, P2115
  • [7] QUANTITATIVE AND KINETIC CHARACTERIZATION OF NITRIC-OXIDE AND EDRF RELEASED FROM CULTURED ENDOTHELIAL-CELLS
    KELM, M
    FEELISCH, M
    SPAHR, R
    PIPER, HM
    NOACK, E
    SCHRADER, J
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1988, 154 (01) : 236 - 244
  • [8] MAEDA H, 1989, CRIT REV THER DRUG, V6, P193
  • [9] SMANCS AND POLYMER-CONJUGATED MACROMOLECULAR DRUGS - ADVANTAGES IN CANCER-CHEMOTHERAPY
    MAEDA, H
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 1991, 6 (02) : 181 - 202
  • [10] CONJUGATES OF ANTICANCER AGENTS AND POLYMERS - ADVANTAGES OF MACROMOLECULAR THERAPEUTICS INVIVO
    MAEDA, H
    SEYMOUR, LW
    MIYAMOTO, Y
    [J]. BIOCONJUGATE CHEMISTRY, 1992, 3 (05) : 351 - 362